RAVINDER SHARMA: Open Payments
NPI 1518954254 · HILLSDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 42 payments from 7 companies in 2025. Trend: 2023 $226 · 2024 $359 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $234 |
| Otsuka America Pharmaceutical, Inc. | 18 | $229 |
| Axsome Therapeutics, Inc. | 5 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $182 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: ARISTADA, Auvelity, CAPLYTA, ABILIFY MAINTENA, REXULTI, COBENFY, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
